The market for Platelet Rich Plasma (PRP) Market is expected to reach XX Bn in 2023.
Platelet-rich plasma (PRP) is a product that contains a large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because it provides a unique ability to augment the wound healing process and osteogenesis. PRP functions as a safe, biocompatible, prompt hemostatic agent and fast-tracks epidermal, epithelial, and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing, and reverses inhibition of glucocorticoid-induced healing. The high concentration of leukocytes in PRP offers an additional antimicrobial effect.
PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery, aesthetics, burn and wound healing, cardiovascular surgery, oral and maxillofacial surgical procedures, and others. PRP has proven effective in treating chronic non-healing wounds and has been adopted as an antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability of grafted tissue at the recipient site owing to its adhesive and cohesive properties.
Type
Others (Otorhinolaryngology-Head and Neck Surgery, Oral and Maxillofacial Surgery, Periodontal Surgery, Urology, Cardiothoracic Surgery, etc.)
Geography
Arthrex, Inc., Arteriocyte Medical Systems, Inc., DePuy Synthes, Inc., Biomet, Inc., Cesca Therapeutics, Inc., Dr. PRP America LLC, EmCyte Corporation, AdiStem Ltd., Exactech, Inc., Nuo Therapeutics, Inc., Regen Lab SA, Harvest Technologies Corp., and several others
The market for Platelet Rich Plasma (PRP) Market is expected to reach XX Bn in 2023.
The Platelet Rich Plasma (PRP) Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2016-2023.
The base year of this report is 2015